W2476 represses TXNIP transcription via dephosphorylation of FOXO1 at Ser319
文献类型:期刊论文
作者 | Zhong, Li2,3; Liu, Qing2; Liu, Qiaofeng1; Zhang, Shikai4; Cao, Yongbing4; Yang, Dehua2![]() ![]() |
刊名 | CHEMICAL BIOLOGY & DRUG DESIGN
![]() |
出版日期 | 2021-02-16 |
页码 | 11 |
关键词 | chromatin immunoprecipitation diabetes transcription TXNIP W2476 |
ISSN号 | 1747-0277 |
DOI | 10.1111/cbdd.13828 |
通讯作者 | Yang, Dehua(dhyang@simm.ac.cn) ; Wang, Ming-Wei(mwwang@simm.ac.cn) |
英文摘要 | Thioredoxin-interacting protein (TXNIP) overexpression is implicated in the pathogenesis of type 2 diabetes. Previous studies have shown that a small molecule compound (W2476) was able to improve beta-cell dysfunction and exert therapeutic effects in diabetic mice via repression of TXNIP signaling pathway. The impact of W2476 on TXNIP transcription was thus investigated using the chromatin immunoprecipitation method. It was found that W2476 promotes competitive binding of forkhead box O1 transcription factor (FOXO1) to the carbohydrate response element (ChoRE) sequence associated with ChoRE-binding protein (ChREBP)/Mlx interacting protein-like(Mlx) complexes. This interaction hinders the attachment of histone acetyltransferase p300 and reduces histone H4 acetylation on the TXNIP promoter, leading to decreasing TXNIP transcription. |
资助项目 | National Natural Science Foundation of China[81872915] ; National Natural Science Foundation of China[81973373] ; National Natural Science Foundation of China[81773792] ; National Science & Technology Major Project[2018ZX09735-001] ; National Science & Technology Major Project[2018ZX09711002-002-005] ; National Science & Technology Major Project[2018ZX09711002-002-011] ; National Key R&D Program of China[2018YFA0507000] ; Novo Nordisk-CAS Research Fund[NNCAS-2017-1-CC] |
WOS研究方向 | Biochemistry & Molecular Biology ; Pharmacology & Pharmacy |
语种 | 英语 |
WOS记录号 | WOS:000618522700001 |
出版者 | WILEY |
源URL | [http://119.78.100.183/handle/2S10ELR8/295812] ![]() |
专题 | 中国科学院上海药物研究所 |
通讯作者 | Yang, Dehua; Wang, Ming-Wei |
作者单位 | 1.Fudan Univ, Sch Pharm, Shanghai, Peoples R China 2.Chinese Acad Sci, Natl Ctr Drug Screening, CAS Key Lab Receptor Res, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China 3.Univ Chinese Acad Sci, Beijing, Peoples R China 4.Shanghai Univ Tradit Chinese Med, Shanghai TCM Integrated Hosp, Shanghai, Peoples R China |
推荐引用方式 GB/T 7714 | Zhong, Li,Liu, Qing,Liu, Qiaofeng,et al. W2476 represses TXNIP transcription via dephosphorylation of FOXO1 at Ser319[J]. CHEMICAL BIOLOGY & DRUG DESIGN,2021:11. |
APA | Zhong, Li.,Liu, Qing.,Liu, Qiaofeng.,Zhang, Shikai.,Cao, Yongbing.,...&Wang, Ming-Wei.(2021).W2476 represses TXNIP transcription via dephosphorylation of FOXO1 at Ser319.CHEMICAL BIOLOGY & DRUG DESIGN,11. |
MLA | Zhong, Li,et al."W2476 represses TXNIP transcription via dephosphorylation of FOXO1 at Ser319".CHEMICAL BIOLOGY & DRUG DESIGN (2021):11. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。